Stoxx Europe 50
|
5 357,10
|
36,43
|
0,68 %
|
Analysen zu Stoxx Europe 50-Werten
| 31.01.25 | Shell Outperform | RBC Capital Markets | |
| 31.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 31.01.25 | Roche Sell | Deutsche Bank AG | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB Sell | Deutsche Bank AG | |
| 31.01.25 | Roche Neutral | UBS AG | |
| 31.01.25 | L'Oréal Neutral | UBS AG | |
| 31.01.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Shell Buy | UBS AG | |
| 31.01.25 | BBVA Buy | Deutsche Bank AG | |
| 31.01.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Rheinmetall Buy | Deutsche Bank AG | |
| 31.01.25 | Sanofi Hold | Deutsche Bank AG | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | ASML NV Outperform | Bernstein Research | |
| 31.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Shell Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Shell Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell Outperform | RBC Capital Markets | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | ASML NV Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.25 | ASML NV Buy | Deutsche Bank AG | |
| 30.01.25 | Sanofi Outperform | Bernstein Research | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | ABB Underperform | Bernstein Research | |
| 30.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 30.01.25 | Schneider Electric Outperform | Bernstein Research | |
| 30.01.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | EssilorLuxottica Neutral | UBS AG | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.